FDA Inspection 833833 — Northwestern Medicine

Northwestern Medicine — FEI 3004743924

The FDA completed an inspection of Northwestern Medicine on June 4, 2013 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 4, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Chicago, IL (United States)